Clinical trial
Hepatic Resection Versus Radiofrequency Ablation for Patients With Hepatocellular Carcinoma and Portal Hypertension
NCT02192671 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepatic Resection Versus Radiofrequency Ablation for Patients With Hepatocellular Carcinoma and Portal Hypertension
- Lead sponsor
- Guangxi Medical University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 31, 2015
- Completion date
- December 31, 2022
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.